Finance and markets: business, quotes, gold, energy and releases.
Found 50395 articles
Investors who purchased Replimune Group securities face an October 5, 2026, deadline to seek appointment as lead plaintiff in a class action lawsuit. The litigation follows a sharp decline in the company’s stock price triggered by a regulatory rejection of its lead drug candidate, RP1, by the FDA.
A sharp 5.63% drop in Jackson Financial’s stock price has triggered a formal investigation by Pomerantz LLP. Shareholders are now under scrutiny to determine whether the company’s leadership engaged in securities fraud by allegedly using complex reinsurance arrangements to obscure significant hedge losses and manipulate corporate solvency metrics.
Investors who suffered losses in Baidu, Inc. securities now face a critical deadline to join a class action lawsuit alleging securities fraud. The litigation centers on claims that the company misled shareholders regarding the stability and growth of its core business segments during 2025 and 2026.
A 29% single-day stock collapse following an unexpected CEO departure and missed revenue targets has triggered a formal investigation by Pomerantz LLP. The firm is now examining whether Cellebrite DI Ltd. misled shareholders regarding its financial health or engaged in unlawful business practices during the lead-up to its second-quarter earnings report.
A 9% slide in Astrana Health stock has triggered a formal inquiry from Pomerantz LLP, which is now investigating potential securities fraud at the company. The firm is currently evaluating whether leadership misled shareholders regarding the financial health and organic growth strategies behind the NASDAQ-listed healthcare provider.
Investors who acquired Babcock & Wilcox Enterprises, Inc. securities between November 5, 2025, and March 11, 2026, are being urged to contact legal counsel. Pomerantz LLP has filed a class action lawsuit alleging financial misconduct during this period, targeting potential losses incurred by shareholders of the New York-listed company.
A 41 percent plunge in Cellectis S.A. stock has triggered a formal investigation by Pomerantz LLP into potential securities fraud. The inquiry follows the company's abrupt decision to abandon key CAR-T cell therapy programs, a move executives attributed to severe capital constraints and unfavorable development timelines.
Investors who purchased FuelCell Energy securities during the designated class period now face a November 10, 2026, deadline to seek status as Lead Plaintiff. Pomerantz LLP has filed a class action lawsuit against the company, centering on allegations that leadership engaged in securities fraud and deceptive business practices.
A 13.7% drop in Corning Incorporated’s share price has triggered a formal investigation by the Pomerantz Law Firm. The inquiry focuses on whether the company or its leadership engaged in securities fraud or unlawful business practices following a major equity offering announcement earlier this month.
Following a sharp 15.67% drop in share price, the Pomerantz Law Firm has launched an investigation into NuScale Power Corporation. Attorneys are examining potential securities fraud and unlawful business practices, specifically focusing on whether the company misled investors regarding its competitive standing and long-term financial health within the modular reactor sector.
A 14.67% single-day collapse in The Cooper Companies' stock price has triggered a formal investigation by Pomerantz LLP. The firm is currently probing whether the medical device manufacturer and its leadership engaged in securities fraud or unlawful business practices following a disappointing third-quarter earnings report released on September 9, 2026.
A 9.19% stock drop in August followed by a 15.36% collapse in September has prompted the Pomerantz Law Firm to launch an investigation into Fluence Energy, Inc. Legal representatives are now examining whether the company’s officers engaged in securities fraud or unlawful business practices following repeated downward revisions of financial guidance.
Investors who suffered losses in Doximity, Inc. are facing a November 16, 2026, deadline to seek status as lead plaintiffs in a class action lawsuit. Pomerantz LLP alleges the company engaged in securities fraud, following a series of stock price drops triggered by missed revenue targets and decelerated growth.
A 6.95% single-day stock price drop following HCA Healthcare’s lowered profit guidance has triggered an investigation by New York-based Pomerantz LLP. The legal firm is examining whether the company and its leadership engaged in securities fraud or unlawful business practices during the second quarter of 2026.
A 13 percent single-day stock slide has triggered a formal investigation into Rent the Runway, as legal analysts probe whether the fashion rental firm misled investors. The inquiry centers on potential securities fraud following a sharp decline in subscribers and a sudden pivot toward dilutive financing measures.
Shares of Endava plummeted nearly 25 percent this week after the company placed Chief Financial Officer Mark Thurston on administrative leave. The sudden move, triggered by an internal probe into accounting practices surrounding specific customer and supplier agreements, has prompted the New York-based Pomerantz LLP to launch a formal securities fraud investigation.
A 23.8% single-day stock plunge has triggered a formal investigation into The Children's Place, Inc. by the law firm Pomerantz LLP. The inquiry centers on whether the retailer’s leadership misled shareholders regarding financial health and the operational failures that led to a significant quarterly earnings miss.
A 34.61% single-day stock plunge followed by the firing of its CEO has prompted Pomerantz LLP to open an investigation into Anavex Life Sciences. The legal firm is now scrutinizing whether the biotechnology company and its leadership engaged in securities fraud or unlawful business practices.
Investors who suffered losses in Ardelyx, Inc. are now eligible to join a class action lawsuit following a sharp decline in share value. The legal action, led by Pomerantz LLP, centers on allegations of securities fraud and unlawful business practices stemming from mid-year adjustments to the company’s financial projections.
A 23 percent single-day stock collapse followed by a federal cybersecurity settlement has prompted a class action lawsuit against Honeywell Aerospace. Investors who suffered losses during the specified period now have until November 23, 2026, to petition the court for lead plaintiff status in the ongoing securities fraud litigation.
A 13.3% single-day collapse in J.B. Hunt Transport Services stock has triggered a formal investigation by Pomerantz LLP. The firm is scrutinizing the logistics company for potential securities fraud and unlawful business practices after management disclosed an unexpected margin squeeze earlier this month.
Investors who suffered losses on The Simply Good Foods Company stock have until October 13, 2026, to apply for lead plaintiff status in a newly filed class action lawsuit. The litigation centers on allegations that the firm obscured critical product defects that ultimately triggered a sharp decline in market value.
Shareholders who suffered financial losses following the April 2026 initial public offering of AEVEX Corp. have until October 20 to petition the court for lead plaintiff status. The class action litigation centers on allegations that company leadership misled investors regarding a secret plan to waive critical stock lock-up restrictions.
After a two-year collaborative effort with Raytheon, defense contractor Lyntris has successfully qualified its in-house wedgelock assembly for the U.S. Navy’s SPY-6 radar family. This milestone aims to resolve long-standing supply chain bottlenecks for the high-power maritime systems currently deployed across the fleet.
Scholastic Corporation reported a first-quarter operating loss of $92.2 million for the period ending August 31, 2026, as the publisher navigated a seasonally quiet quarter characterized by reduced school budget spending and the lingering financial impact of recent sale-leaseback transactions.
The National Organization for Rare Disorders has unveiled its 2026 Rare Impact Award honorees, recognizing a diverse cohort of biopharmaceutical companies, medical scientists, and community advocates who are reshaping care for the 30 million Americans currently navigating the complexities of rare and often life-limiting genetic conditions.
North Texas addiction and mental health provider Enterhealth and its chief medical officer, Dr. Umar Latif, have been named finalists for the 2026 Excellence in Healthcare Awards. The program, hosted by D CEO, selected 77 finalists from over 200 nominations to honor those driving significant clinical impact in the region.
Legacy Education Inc. posted a strong fiscal year 2026, with annual revenue climbing 24.8% to $80.1 million. The healthcare-focused career educator saw net income rise to $9.1 million, bolstered by a 9% surge in new student starts and an expanded footprint that now includes a planned campus in Houston, Texas.
IM Cannabis Corp. has closed a $1.31 million registered direct offering, selling 655,000 common shares at $2.00 each to accredited investors. The company plans to use the capital to bolster its working capital and support general corporate operations as it navigates ongoing financial challenges.
Before the New York Stock Exchange bell rings on October 28, 2026, International Paper will disclose its financial performance for the third quarter. The Memphis-based packaging giant plans to pair the release with a live webcast to dissect current market conditions and broader corporate results.